| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 3.58e-05 | 92 | 138 | 6 | GO:0051057 | |
| GeneOntologyBiologicalProcess | negative regulation of cell proliferation involved in heart valve morphogenesis | 4.44e-05 | 2 | 138 | 2 | GO:0003252 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | VLDLR RELN ANK3 NRDC APC LAMA2 LAMC1 ZFPM1 ARHGAP35 DSCAML1 BRWD3 BTBD3 MYO3A BMPR2 HMCN2 WASF2 PKHD1 MACF1 DNMBP UNC13A NOTCH1 | 4.49e-05 | 1194 | 138 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | PDE4B NRDC ARID4A ABCA12 APC LAMA2 IL20RB LAMC1 TNFRSF11A ZFPM1 KMT2E ITGAM LEPR CSF1 PLCL2 RP1 FH MUC2 NOTCH1 | 6.77e-05 | 1043 | 138 | 19 | GO:0048871 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | VLDLR RELN ANK3 NRDC APC LAMA2 LAMC1 ARHGAP35 DSCAML1 BTBD3 BMPR2 HMCN2 WASF2 MACF1 UNC13A NOTCH1 | 1.20e-04 | 819 | 138 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | VLDLR RELN NRDC APC KAT2A ARHGAP35 MYO3A KAT2B BMPR2 WASF2 MACF1 RP1 | 1.24e-04 | 494 | 138 | 12 | GO:0031346 |
| GeneOntologyBiologicalProcess | mitral valve morphogenesis | 1.26e-04 | 15 | 138 | 3 | GO:0003183 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.31e-04 | 285 | 138 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | VLDLR RELN ANK3 NRDC APC LAMA2 LAMC1 ARHGAP35 DSCAML1 BTBD3 BMPR2 HMCN2 WASF2 MACF1 UNC13A NOTCH1 | 1.32e-04 | 826 | 138 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of cell proliferation involved in heart valve morphogenesis | 1.33e-04 | 3 | 138 | 2 | GO:0003250 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in heart valve morphogenesis | 1.33e-04 | 3 | 138 | 2 | GO:0003249 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.35e-04 | 286 | 138 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | VLDLR RELN ANK3 NRDC APC LAMA2 LAMC1 ARHGAP35 DSCAML1 BTBD3 MYO3A BMPR2 HMCN2 MACF1 NOTCH1 | 1.49e-04 | 748 | 138 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | mitral valve development | 1.54e-04 | 16 | 138 | 3 | GO:0003174 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor activity | 1.86e-04 | 17 | 138 | 3 | GO:0098962 | |
| GeneOntologyBiologicalProcess | negative regulation of cell proliferation involved in heart morphogenesis | 2.64e-04 | 4 | 138 | 2 | GO:2000137 | |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 2.64e-04 | 4 | 138 | 2 | GO:0046352 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in heart valve development | 2.64e-04 | 4 | 138 | 2 | GO:2000793 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | VLDLR RELN ANK3 NRDC APC LAMA2 LAMC1 ARHGAP35 DSCAML1 BTBD3 BMPR2 HMCN2 MACF1 UNC13A NOTCH1 | 3.15e-04 | 802 | 138 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of delayed rectifier potassium channel activity | 3.57e-04 | 21 | 138 | 3 | GO:1902259 | |
| GeneOntologyBiologicalProcess | temperature homeostasis | 3.57e-04 | 196 | 138 | 7 | GO:0001659 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | VLDLR NOP53 APC LAMP2 ICE1 CEP192 KAT2A ARHGAP35 CARD8 MYO3A KAT2B WASF2 ULK4 MACF1 ADGRE5 RP1 TASOR UNC13A NOTCH1 | 3.64e-04 | 1189 | 138 | 19 | GO:0044087 |
| GeneOntologyBiologicalProcess | homeostasis of number of cells within a tissue | 3.76e-04 | 51 | 138 | 4 | GO:0048873 | |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 4.05e-04 | 52 | 138 | 4 | GO:0010824 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 4.23e-04 | 334 | 138 | 9 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 4.23e-04 | 334 | 138 | 9 | GO:0001894 | |
| GeneOntologyBiologicalProcess | axonogenesis | RELN ANK3 NRDC APC LAMA2 LAMC1 ARHGAP35 DSCAML1 BMPR2 HMCN2 MACF1 NOTCH1 | 4.29e-04 | 566 | 138 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | mitral valve formation | 4.39e-04 | 5 | 138 | 2 | GO:0003192 | |
| GeneOntologyBiologicalProcess | regulation of mast cell differentiation | 4.39e-04 | 5 | 138 | 2 | GO:0060375 | |
| Domain | EGF-like_dom | VLDLR FRAS1 RELN LAMA2 LAMC1 LRP1B ADGRL4 EYS MALRD1 HMCN2 ADGRE5 C8A NAGPA NOTCH1 | 3.21e-09 | 249 | 134 | 14 | IPR000742 |
| Domain | EGF | VLDLR FRAS1 RELN LAMA2 LAMC1 LRP1B ADGRL4 EYS MALRD1 ADGRE5 NAGPA NOTCH1 | 1.30e-07 | 235 | 134 | 12 | SM00181 |
| Domain | Growth_fac_rcpt_ | 1.86e-07 | 156 | 134 | 10 | IPR009030 | |
| Domain | EGF-like_CS | VLDLR RELN LAMA2 LAMC1 LRP1B ADGRL4 EYS MALRD1 HMCN2 C8A NAGPA NOTCH1 | 4.01e-07 | 261 | 134 | 12 | IPR013032 |
| Domain | EGF_2 | VLDLR RELN LAMA2 LAMC1 LRP1B ADGRL4 EYS MALRD1 HMCN2 C8A NAGPA NOTCH1 | 4.72e-07 | 265 | 134 | 12 | PS01186 |
| Domain | EGF_3 | VLDLR RELN LRP1B ADGRL4 EYS MALRD1 HMCN2 ADGRE5 C8A NAGPA NOTCH1 | 1.05e-06 | 235 | 134 | 11 | PS50026 |
| Domain | EGF_1 | VLDLR RELN LAMA2 LAMC1 LRP1B EYS MALRD1 HMCN2 C8A NAGPA NOTCH1 | 2.32e-06 | 255 | 134 | 11 | PS00022 |
| Domain | EGF_Ca-bd_CS | 6.28e-06 | 97 | 134 | 7 | IPR018097 | |
| Domain | PbH1 | 7.11e-06 | 6 | 134 | 3 | SM00710 | |
| Domain | PbH1 | 7.11e-06 | 6 | 134 | 3 | IPR006626 | |
| Domain | EGF_CA | 7.19e-06 | 99 | 134 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.69e-06 | 100 | 134 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.13e-05 | 106 | 134 | 7 | IPR000152 | |
| Domain | Pectin_lyase_fold/virulence | 1.97e-05 | 8 | 134 | 3 | IPR011050 | |
| Domain | EGF_CA | 2.82e-05 | 122 | 134 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.13e-05 | 124 | 134 | 7 | IPR001881 | |
| Domain | EGF_CA | 3.58e-05 | 86 | 134 | 6 | PF07645 | |
| Domain | Hist_acetylase_PCAF | 5.11e-05 | 2 | 134 | 2 | IPR016376 | |
| Domain | PCAF_N | 5.11e-05 | 2 | 134 | 2 | IPR009464 | |
| Domain | PCAF_N | 5.11e-05 | 2 | 134 | 2 | PF06466 | |
| Domain | BROMODOMAIN_1 | 1.39e-04 | 37 | 134 | 4 | PS00633 | |
| Domain | Bromodomain | 1.55e-04 | 38 | 134 | 4 | PF00439 | |
| Domain | LDLR_class-A_CS | 1.89e-04 | 40 | 134 | 4 | IPR023415 | |
| Domain | BROMODOMAIN_2 | 2.09e-04 | 41 | 134 | 4 | PS50014 | |
| Domain | Bromodomain | 2.30e-04 | 42 | 134 | 4 | IPR001487 | |
| Domain | BROMO | 2.30e-04 | 42 | 134 | 4 | SM00297 | |
| Domain | - | 2.30e-04 | 42 | 134 | 4 | 1.20.920.10 | |
| Domain | EGF | 2.97e-04 | 126 | 134 | 6 | PF00008 | |
| Domain | Ldl_recept_a | 3.00e-04 | 45 | 134 | 4 | PF00057 | |
| Domain | G8_domain | 3.04e-04 | 4 | 134 | 2 | IPR019316 | |
| Domain | Glyco_hydro_31_CS | 3.04e-04 | 4 | 134 | 2 | IPR030459 | |
| Domain | G8 | 3.04e-04 | 4 | 134 | 2 | PS51484 | |
| Domain | Gal_mutarotase_N | 3.04e-04 | 4 | 134 | 2 | IPR031727 | |
| Domain | G8 | 3.04e-04 | 4 | 134 | 2 | SM01225 | |
| Domain | G8 | 3.04e-04 | 4 | 134 | 2 | PF10162 | |
| Domain | NtCtMGAM_N | 3.04e-04 | 4 | 134 | 2 | PF16863 | |
| Domain | - | 3.27e-04 | 46 | 134 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.86e-04 | 48 | 134 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 4.18e-04 | 49 | 134 | 4 | IPR002172 | |
| Domain | LDLa | 4.18e-04 | 49 | 134 | 4 | SM00192 | |
| Domain | LDLRA_2 | 4.18e-04 | 49 | 134 | 4 | PS50068 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 5.04e-04 | 5 | 134 | 2 | PS00707 | |
| Domain | SAPAP | 5.04e-04 | 5 | 134 | 2 | IPR005026 | |
| Domain | GKAP | 5.04e-04 | 5 | 134 | 2 | PF03359 | |
| Domain | Pectin_lyas_fold | 7.52e-04 | 6 | 134 | 2 | IPR012334 | |
| Domain | SPOC_C | 7.52e-04 | 6 | 134 | 2 | IPR012921 | |
| Domain | Glyco_hydro_31_AS | 7.52e-04 | 6 | 134 | 2 | IPR030458 | |
| Domain | - | 7.52e-04 | 6 | 134 | 2 | 2.160.20.10 | |
| Domain | SPOC | 7.52e-04 | 6 | 134 | 2 | PF07744 | |
| Domain | EGF_extracell | 9.05e-04 | 60 | 134 | 4 | IPR013111 | |
| Domain | EGF_2 | 9.05e-04 | 60 | 134 | 4 | PF07974 | |
| Domain | Glyco_hydro_31 | 1.05e-03 | 7 | 134 | 2 | IPR000322 | |
| Domain | TFS2M | 1.05e-03 | 7 | 134 | 2 | SM00510 | |
| Domain | Glyco_hydro_31 | 1.05e-03 | 7 | 134 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.05e-03 | 7 | 134 | 2 | PS00129 | |
| Domain | TFIIS_M | 1.05e-03 | 7 | 134 | 2 | PF07500 | |
| Domain | TFIIS_cen_dom | 1.39e-03 | 8 | 134 | 2 | IPR003618 | |
| Domain | P_TREFOIL_1 | 1.39e-03 | 8 | 134 | 2 | PS00025 | |
| Domain | - | 1.39e-03 | 8 | 134 | 2 | 1.10.472.30 | |
| Domain | Trefoil | 1.39e-03 | 8 | 134 | 2 | PF00088 | |
| Domain | LAMININ_IVA | 1.39e-03 | 8 | 134 | 2 | PS51115 | |
| Domain | Laminin_B | 1.39e-03 | 8 | 134 | 2 | PF00052 | |
| Domain | TFIIS_CENTRAL | 1.39e-03 | 8 | 134 | 2 | PS51321 | |
| Domain | LamB | 1.39e-03 | 8 | 134 | 2 | SM00281 | |
| Domain | P_trefoil_CS | 1.39e-03 | 8 | 134 | 2 | IPR017957 | |
| Domain | Laminin_IV | 1.39e-03 | 8 | 134 | 2 | IPR000034 | |
| Domain | P_TREFOIL_2 | 1.78e-03 | 9 | 134 | 2 | PS51448 | |
| Domain | PD | 1.78e-03 | 9 | 134 | 2 | SM00018 | |
| Domain | - | 2.69e-03 | 11 | 134 | 2 | 4.10.110.10 | |
| Domain | Laminin_G_1 | 2.69e-03 | 11 | 134 | 2 | PF00054 | |
| Domain | P_trefoil_dom | 3.22e-03 | 12 | 134 | 2 | IPR000519 | |
| Domain | C-type_lectin_CS | 3.61e-03 | 43 | 134 | 3 | IPR018378 | |
| Domain | Ldl_recept_b | 4.39e-03 | 14 | 134 | 2 | PF00058 | |
| Domain | LDLRB | 4.39e-03 | 14 | 134 | 2 | PS51120 | |
| Domain | LY | 5.05e-03 | 15 | 134 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.05e-03 | 15 | 134 | 2 | IPR000033 | |
| Domain | Laminin_N | 5.74e-03 | 16 | 134 | 2 | IPR008211 | |
| Domain | LamNT | 5.74e-03 | 16 | 134 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 5.74e-03 | 16 | 134 | 2 | PS51117 | |
| Domain | Laminin_N | 5.74e-03 | 16 | 134 | 2 | PF00055 | |
| Domain | Gal_mutarotase_SF_dom | 6.48e-03 | 17 | 134 | 2 | IPR011013 | |
| Pathway | WP_GASTRIC_CANCER_NETWORK_1 | 1.27e-06 | 28 | 98 | 5 | M39347 | |
| Pathway | WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM | 1.92e-05 | 80 | 98 | 6 | M45523 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.77e-05 | 10 | 98 | 3 | MM15535 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.12e-04 | 14 | 98 | 3 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.71e-04 | 16 | 98 | 3 | M27121 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 19155216 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 APC LAMC1 CEP192 ITPRID2 CARD8 GAB2 BMPR2 PHF3 STARD9 PI4KB EXO1 MACF1 AKAP13 DNMBP DOP1A | 4.25e-07 | 861 | 140 | 16 | 36931259 |
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 10747963 | ||
| Pubmed | 7.37e-07 | 18 | 140 | 4 | 14730302 | ||
| Pubmed | 1.03e-06 | 130 | 140 | 7 | 12421765 | ||
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 1.27e-06 | 6 | 140 | 3 | 18957219 | |
| Pubmed | DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95. | 2.21e-06 | 7 | 140 | 3 | 9286858 | |
| Pubmed | ErbB4 regulates the timely progression of late fetal lung development. | 2.21e-06 | 7 | 140 | 3 | 20303366 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.23e-06 | 361 | 140 | 10 | 26167880 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRMT9B PRUNE2 ANK3 KIZ ASH1L CEP192 ARHGAP35 ARMC2 BRWD3 RLF ZNF462 PKNOX2 CFAP20DC BMPR2 MACF1 AKAP13 LRBA ICA1L GPA33 DOP1A | 2.32e-06 | 1489 | 140 | 20 | 28611215 |
| Pubmed | PPP4R1 FRAS1 ERBB3 NRDC APC DGKA SRPK1 WASF2 MID1 AKAP13 TASOR TOP3A SLC27A4 | 2.47e-06 | 650 | 140 | 13 | 38777146 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.54e-06 | 101 | 140 | 6 | 23382219 | |
| Pubmed | 3.89e-06 | 225 | 140 | 8 | 12168954 | ||
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 25857663 | ||
| Pubmed | 5.45e-06 | 167 | 140 | 7 | 22159717 | ||
| Pubmed | DLGAP1 ERBB3 TRA PKHD1L1 BTBD3 PKNOX2 DDIAS MYO3A MALRD1 CSF1 NALF1 ADAMTS20 DDX60L UNC13A | 5.68e-06 | 814 | 140 | 14 | 23251661 | |
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 23001180 | ||
| Pubmed | 8.09e-06 | 418 | 140 | 10 | 34709266 | ||
| Pubmed | Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects. | 1.03e-05 | 11 | 140 | 3 | 24051374 | |
| Pubmed | 1.03e-05 | 71 | 140 | 5 | 33541421 | ||
| Pubmed | l7Rn6 encodes a novel protein required for clara cell function in mouse lung development. | 1.37e-05 | 12 | 140 | 3 | 16157679 | |
| Pubmed | 1.37e-05 | 12 | 140 | 3 | 21402781 | ||
| Pubmed | Maternal surfactant protein A influences the immunoprotective properties of milk in a murine model. | 1.61e-05 | 2 | 140 | 2 | 24858142 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24954098 | ||
| Pubmed | Surfactant protein A modulates neuroinflammation in adult mice upon pulmonary infection. | 1.61e-05 | 2 | 140 | 2 | 38964703 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22219327 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15890661 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15385504 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23038062 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17307210 | ||
| Pubmed | Surfactant protein A modulates induction of regulatory T cells via TGF-β. | 1.61e-05 | 2 | 140 | 2 | 22474025 | |
| Pubmed | Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice. | 1.61e-05 | 2 | 140 | 2 | 38553537 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34270849 | ||
| Pubmed | Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum. | 1.61e-05 | 2 | 140 | 2 | 33510368 | |
| Pubmed | Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. | 1.61e-05 | 2 | 140 | 2 | 11342662 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 2050021 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 31878840 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12922979 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30188895 | ||
| Pubmed | Novel role for surfactant protein A in gastrointestinal graft-versus-host disease. | 1.61e-05 | 2 | 140 | 2 | 22508928 | |
| Pubmed | Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation. | 1.61e-05 | 2 | 140 | 2 | 29669932 | |
| Pubmed | Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4. | 1.61e-05 | 2 | 140 | 2 | 35444643 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11867335 | ||
| Pubmed | SP-A preserves airway homeostasis during Mycoplasma pneumoniae infection in mice. | 1.61e-05 | 2 | 140 | 2 | 19494306 | |
| Pubmed | Characterization of a second human pulmonary surfactant-associated protein SP-A gene. | 1.61e-05 | 2 | 140 | 2 | 1372511 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21205009 | ||
| Pubmed | Surfactant protein A binds flagellin enhancing phagocytosis and IL-1β production. | 1.61e-05 | 2 | 140 | 2 | 24312669 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17580966 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32340123 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18794118 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19470682 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30582451 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20448439 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24080545 | ||
| Pubmed | Murine pulmonary surfactant SP-A gene: cloning, sequence, and transcriptional activity. | 1.61e-05 | 2 | 140 | 2 | 1443158 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27835691 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27480812 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34484180 | ||
| Pubmed | Obesity enhances gastrointestinal tumorigenesis in Apc-mutant mice. | 1.61e-05 | 2 | 140 | 2 | 18725892 | |
| Pubmed | Surfactant protein-A reduces translocation of mediators from the lung into the circulation. | 1.61e-05 | 2 | 140 | 2 | 20715984 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19232344 | ||
| Pubmed | Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms. | 1.61e-05 | 2 | 140 | 2 | 18159253 | |
| Pubmed | Regulatory roles of SP-A and exosomes in pneumonia-induced acute lung and kidney injuries. | 1.61e-05 | 2 | 140 | 2 | 37256132 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30951821 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33267655 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 10781424 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 26635527 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29202868 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20693318 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15502373 | ||
| Pubmed | Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. | 1.61e-05 | 2 | 140 | 2 | 22863622 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12363388 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9922219 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34917085 | ||
| Pubmed | A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation. | 1.61e-05 | 2 | 140 | 2 | 23475791 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12351151 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29394894 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11027331 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 31562368 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19392648 | ||
| Pubmed | Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. | 1.61e-05 | 2 | 140 | 2 | 9126996 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 8628397 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19335775 | ||
| Pubmed | Differences in the alveolar macrophage toponome in humanized SP-A1 and SP-A2 transgenic mice. | 1.61e-05 | 2 | 140 | 2 | 33141765 | |
| Pubmed | DOCK4 stimulates MUC2 production through its effect on goblet cell differentiation. | 1.61e-05 | 2 | 140 | 2 | 33559155 | |
| Pubmed | Innate immunity of surfactant protein A in experimental otitis media. | 1.61e-05 | 2 | 140 | 2 | 31378117 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11237812 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27916681 | ||
| Pubmed | Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. | 1.61e-05 | 2 | 140 | 2 | 12959932 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15044702 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 1986781 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12740217 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18083768 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 35322074 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9700084 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20963503 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25605768 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12959946 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25269644 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28678170 | ||
| GeneFamily | Classical BAR domain containing | 7.97e-04 | 8 | 98 | 2 | 1292 | |
| GeneFamily | Collectins | 1.27e-03 | 10 | 98 | 2 | 491 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.35e-03 | 394 | 98 | 8 | 471 | |
| GeneFamily | Laminin subunits | 1.85e-03 | 12 | 98 | 2 | 626 | |
| GeneFamily | ATAC complex | 2.18e-03 | 13 | 98 | 2 | 1058 | |
| GeneFamily | Low density lipoprotein receptors | 2.18e-03 | 13 | 98 | 2 | 634 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 3.75e-03 | 17 | 98 | 2 | 1059 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.75e-03 | 17 | 98 | 2 | 486 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ATG4A DOCK4 PDE4B LPAR4 ARID4A TRPC1 ASH1L ITPRID2 GAB2 BTBD3 ADGRL4 PTPN12 GIMAP8 MACF1 ELF1 ADGRE5 LRBA TASOR | 6.59e-07 | 854 | 139 | 18 | M1533 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 VLDLR ARID4A CENPF TRPC1 APC LAMC1 ARHGAP35 RLF PTPN12 NALF1 PHF3 MID1 MACF1 AKAP13 DNMBP TASOR TP53BP1 | 6.81e-07 | 856 | 139 | 18 | M4500 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | VLDLR RELN ANK3 ASH1L LAMA2 DGKA LAMC1 GRIA2 ZFPM1 ARHGAP35 KMT2E ADGRL4 PTPN12 MACF1 ADGRE5 TP53BP1 | 1.49e-06 | 721 | 139 | 16 | M1999 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PDCD1 PDE4B NRDC ARID4A NOP53 ASH1L DGKA ICE1 ARHGAP35 KMT2E BIRC6 CARD8 KAT2B CSF1 GIMAP8 PHF3 MACF1 ELF1 AKAP13 ADGRE5 LRBA TASOR NOTCH1 | 3.73e-06 | 1492 | 139 | 23 | M40023 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | DOCK4 PDE4B LPAR4 ARID4A TRPC1 ASH1L ITPRID2 GAB2 BTBD3 ADGRL4 PTPN12 GIMAP8 MACF1 ELF1 ADGRE5 LRBA TASOR | 5.00e-06 | 888 | 139 | 17 | MM1018 |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN | 1.07e-05 | 197 | 139 | 8 | M3438 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 DOCK4 RELN ANK3 ARID4A APC GRIA2 ARHGAP35 KMT2E LRP1B DSCAML1 ZNF462 NALF1 MUC2 ICA1L UNC13A CALN1 DOP1A | 2.34e-05 | 1106 | 139 | 18 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.46e-05 | 221 | 139 | 8 | M39222 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.34e-05 | 300 | 139 | 9 | M8702 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | LPAR4 ARID4A LAMA2 LAMC1 ITPRID2 KAT2B CSF1 PI4KB AKAP13 TASOR | 4.51e-05 | 389 | 139 | 10 | M6520 |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 7.24e-05 | 131 | 139 | 6 | M40316 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 8.18e-05 | 194 | 139 | 7 | M8864 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 9.00e-05 | 197 | 139 | 7 | M9569 | |
| Coexpression | GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN | 9.29e-05 | 198 | 139 | 7 | M9882 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 9.59e-05 | 199 | 139 | 7 | M5893 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 9.59e-05 | 199 | 139 | 7 | M5406 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 9.89e-05 | 200 | 139 | 7 | M5055 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-09 | 150 | 140 | 9 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.44e-09 | 178 | 140 | 9 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-08 | 160 | 140 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-08 | 160 | 140 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.28e-08 | 168 | 140 | 8 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 6.88e-08 | 170 | 140 | 8 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.53e-08 | 172 | 140 | 8 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 8.99e-08 | 176 | 140 | 8 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.21e-07 | 183 | 140 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.49e-07 | 188 | 140 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-07 | 189 | 140 | 8 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.56e-07 | 189 | 140 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-07 | 193 | 140 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.24e-07 | 141 | 140 | 7 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.50e-07 | 148 | 140 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 170 | 140 | 7 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 170 | 140 | 7 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 170 | 140 | 7 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-06 | 177 | 140 | 7 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-06 | 181 | 140 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 184 | 140 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-06 | 185 | 140 | 7 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 186 | 140 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 187 | 140 | 7 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-06 | 187 | 140 | 7 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.32e-06 | 189 | 140 | 7 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-06 | 189 | 140 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.32e-06 | 189 | 140 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-06 | 190 | 140 | 7 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 190 | 140 | 7 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-06 | 192 | 140 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.66e-06 | 193 | 140 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-06 | 193 | 140 | 7 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 195 | 140 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.24e-06 | 128 | 140 | 6 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.37e-06 | 200 | 140 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-06 | 200 | 140 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.54e-06 | 130 | 140 | 6 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 5.43e-06 | 140 | 140 | 6 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-06 | 143 | 140 | 6 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 7.47e-06 | 148 | 140 | 6 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-05 | 159 | 140 | 6 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.21e-05 | 161 | 140 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 167 | 140 | 6 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 169 | 140 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 171 | 140 | 6 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 172 | 140 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 173 | 140 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 173 | 140 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 173 | 140 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.88e-05 | 174 | 140 | 6 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 175 | 140 | 6 | 43be63976da5ad0764d24d90919a77ce46068f52 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 175 | 140 | 6 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 175 | 140 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-05 | 176 | 140 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 179 | 140 | 6 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 179 | 140 | 6 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 2.20e-05 | 179 | 140 | 6 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-05 | 180 | 140 | 6 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 181 | 140 | 6 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.42e-05 | 182 | 140 | 6 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 182 | 140 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.49e-05 | 183 | 140 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 183 | 140 | 6 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.49e-05 | 183 | 140 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.49e-05 | 183 | 140 | 6 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-05 | 184 | 140 | 6 | 30ca56d64c961127e26122613e35aa2b46fde2df | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.65e-05 | 185 | 140 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 185 | 140 | 6 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.65e-05 | 185 | 140 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 185 | 140 | 6 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 186 | 140 | 6 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 186 | 140 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.73e-05 | 186 | 140 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.81e-05 | 187 | 140 | 6 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.81e-05 | 187 | 140 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.81e-05 | 187 | 140 | 6 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-05 | 188 | 140 | 6 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.90e-05 | 188 | 140 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-05 | 188 | 140 | 6 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 188 | 140 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-05 | 188 | 140 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-05 | 188 | 140 | 6 | 0da6d6d3c28e9d99159b1a24a345a2250e8e1995 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-05 | 188 | 140 | 6 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 189 | 140 | 6 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 2.99e-05 | 189 | 140 | 6 | 8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 189 | 140 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.99e-05 | 189 | 140 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 189 | 140 | 6 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|COVID-19_Convalescent / Disease condition and Cell class | 2.99e-05 | 189 | 140 | 6 | 732e8dcffcb634ca2968f9170c9c4b31dd5d4206 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 189 | 140 | 6 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 189 | 140 | 6 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 190 | 140 | 6 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-05 | 190 | 140 | 6 | 32400c62cb9de4c2b24af4206c21a0215ab12212 | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.08e-05 | 190 | 140 | 6 | 279c5f68b993dc7adbf9aa69fffb1321cdebc48a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.08e-05 | 190 | 140 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 190 | 140 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| Disease | Schizophrenia | DOCK4 DLGAP2 VLDLR DLGAP1 ERBB3 RELN PDE4B ANK3 APC LAMA2 GRIA2 ITGAM PKNOX2 PLCL2 FADS2 ULK4 | 3.66e-06 | 883 | 137 | 16 | C0036341 |
| Disease | Manic Disorder | 2.04e-05 | 71 | 137 | 5 | C0024713 | |
| Disease | Manic | 3.22e-05 | 78 | 137 | 5 | C0338831 | |
| Disease | Depression, Bipolar | 3.43e-05 | 79 | 137 | 5 | C0005587 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 7.42e-05 | 150 | 137 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | Abnormality of refraction | AKAP6 ANK3 LAMA2 BIRC6 DSCAML1 ZNF462 ADAMTS20 ULK4 AKAP13 CALN1 SLC4A11 RBX1 | 7.47e-05 | 673 | 137 | 12 | HP_0000539 |
| Disease | Bipolar Disorder | 8.17e-05 | 477 | 137 | 10 | C0005586 | |
| Disease | Myopia | 8.24e-05 | 385 | 137 | 9 | HP_0000545 | |
| Disease | PR interval | AKAP6 DOCK4 ARID4A ABCA12 LAMC1 ZFPM1 MYO3A BMPR2 FADS2 MACF1 | 1.11e-04 | 495 | 137 | 10 | EFO_0004462 |
| Disease | smoking cessation | 1.45e-04 | 325 | 137 | 8 | EFO_0004319 | |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum | 2.12e-04 | 5 | 137 | 2 | OBA_2042200 | |
| Disease | Congenital ichthyosis | 2.12e-04 | 5 | 137 | 2 | C0020758 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 2.12e-04 | 5 | 137 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | level of prosaposin in blood serum | 2.12e-04 | 5 | 137 | 2 | OBA_2044552 | |
| Disease | cortical thickness | AKAP6 TRMT9B ERBB3 RELN LAMA2 LAMC1 ARHGAP35 ZNF462 MALRD1 NALF1 SLCO1A2 PKHD1 ADAMTS20 FADS2 MACF1 | 2.14e-04 | 1113 | 137 | 15 | EFO_0004840 |
| Disease | Autistic Disorder | 2.26e-04 | 261 | 137 | 7 | C0004352 | |
| Disease | red blood cell density measurement | VLDLR LAMC1 ADGRL4 ZNF462 KAT2B PNPLA1 GIMAP8 PLCL2 PKHD1 FADS2 ULK4 AKAP13 TASOR | 2.41e-04 | 880 | 137 | 13 | EFO_0007978 |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.52e-04 | 447 | 137 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | cholesteryl ester 14:0 measurement | 2.64e-04 | 27 | 137 | 3 | EFO_0010340 | |
| Disease | alkaline phosphatase measurement | ATG16L1 TNFRSF11A ZFPM1 LEPR MYO3A FADS2 MACF1 ELF1 AKAP13 RP1 LRBA CLEC10A NOTCH1 TP53BP1 | 2.78e-04 | 1015 | 137 | 14 | EFO_0004533 |
| Disease | newborn respiratory distress syndrome (biomarker_via_orthology) | 3.17e-04 | 6 | 137 | 2 | DOID:12716 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:0_20:2) in blood serum | 3.17e-04 | 6 | 137 | 2 | OBA_2045092 | |
| Disease | anorexia nervosa | 3.22e-04 | 70 | 137 | 4 | MONDO_0005351 | |
| Disease | cognitive function measurement | AKAP6 PPP4R1 IL20RB CEP192 KMT2E BIRC6 LRP1B ADGRL4 MYO3A NALF1 PLCL2 PKHD1 ZNF799 MUC2 ZNF443 CALN1 RBX1 | 3.62e-04 | 1434 | 137 | 17 | EFO_0008354 |
| Disease | verbal-numerical reasoning measurement | 3.74e-04 | 131 | 137 | 5 | EFO_0008394 | |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 4.43e-04 | 7 | 137 | 2 | DOID:12716 (is_implicated_in) | |
| Disease | Rectal Neoplasms | 4.43e-04 | 7 | 137 | 2 | C0034885 | |
| Disease | 1-eicosatrienoylglycerophosphocholine measurement | 4.43e-04 | 7 | 137 | 2 | EFO_0021081 | |
| Disease | Rectal Carcinoma | 4.43e-04 | 7 | 137 | 2 | C0007113 | |
| Disease | neuroimaging measurement | ERBB3 RELN ANK3 APC LAMA2 LAMC1 ARHGAP35 ZNF462 NALF1 PKHD1 ADAMTS20 FADS2 MACF1 ICA1L | 4.67e-04 | 1069 | 137 | 14 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | AKAP6 ERBB3 CENPF LAMA2 LEPR BMPR2 CSF1 EXO1 MACF1 LRBA SPOCD1 NOTCH1 TP53BP1 DOP1A | 4.89e-04 | 1074 | 137 | 14 | C0006142 |
| Disease | age at menopause | 5.43e-04 | 302 | 137 | 7 | EFO_0004704 | |
| Disease | otosclerosis | 5.61e-04 | 81 | 137 | 4 | EFO_0004213 | |
| Disease | 2-arachidonoyl-GPE (20:4) measurement | 5.88e-04 | 8 | 137 | 2 | EFO_0800260 | |
| Disease | 1-linoleoyl-GPE (18:2) measurement | 5.88e-04 | 8 | 137 | 2 | EFO_0800247 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 5.88e-04 | 8 | 137 | 2 | EFO_0801768 | |
| Disease | human immunodeficiency virus infectious disease (is_marker_for) | 6.25e-04 | 36 | 137 | 3 | DOID:526 (is_marker_for) | |
| Disease | mean corpuscular hemoglobin concentration | ARID4A SRPK1 ZFPM1 LIN9 LEPR ADGRL4 KAT2B BMPR2 PLCL2 EXO1 FADS2 MACF1 ELF1 AKAP13 | 6.46e-04 | 1105 | 137 | 14 | EFO_0004528 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.35e-04 | 152 | 137 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Gastrointestinal Hemorrhage | 7.54e-04 | 9 | 137 | 2 | C0017181 | |
| Disease | Osteitis Deformans | 7.54e-04 | 9 | 137 | 2 | C0029401 | |
| Disease | Colon Carcinoma | 7.54e-04 | 9 | 137 | 2 | C0699790 | |
| Disease | body surface area | 8.68e-04 | 643 | 137 | 10 | EFO_0022196 | |
| Disease | testosterone measurement | DOCK4 DLGAP1 PDE4B ANK3 NRDC BIRC6 LEPR PKNOX2 KAT2B NALF1 SLCO1A2 MACF1 ZNF799 DNMBP SPOCD1 | 8.81e-04 | 1275 | 137 | 15 | EFO_0004908 |
| Disease | rectum cancer | 9.85e-04 | 42 | 137 | 3 | EFO_1000657 | |
| Disease | aspartate aminotransferase measurement | ERBB3 ARHGAP35 BIRC6 LEPR GAB2 PKNOX2 CSF1 HMCN2 ELF1 AKAP13 LRBA DNMBP | 1.07e-03 | 904 | 137 | 12 | EFO_0004736 |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 1.15e-03 | 11 | 137 | 2 | C0079154 | |
| Disease | Congenital ichthyosis of skin | 1.15e-03 | 11 | 137 | 2 | cv:C0020758 | |
| Disease | serum gamma-glutamyl transferase measurement | ASH1L ZFPM1 ARHGAP35 KAT2B EYS SLCO1A2 PKHD1 AKAP13 RP1 LRBA DNMBP TP53BP1 | 1.17e-03 | 914 | 137 | 12 | EFO_0004532 |
| Disease | Intellectual Disability | 1.19e-03 | 447 | 137 | 8 | C3714756 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.20e-03 | 346 | 137 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | neuritic plaque measurement | 1.26e-03 | 349 | 137 | 7 | EFO_0006798 | |
| Disease | ficolin-3 measurement | 1.37e-03 | 12 | 137 | 2 | EFO_0020392 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 1.37e-03 | 12 | 137 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 1.37e-03 | 12 | 137 | 2 | EFO_0008141 | |
| Disease | Intestinal Neoplasms | 1.37e-03 | 12 | 137 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 1.37e-03 | 12 | 137 | 2 | C0346627 | |
| Disease | autistic disorder (is_marker_for) | 1.37e-03 | 12 | 137 | 2 | DOID:12849 (is_marker_for) | |
| Disease | cognitive function measurement, self reported educational attainment | 1.39e-03 | 355 | 137 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | rheumatoid arthritis | 1.46e-03 | 462 | 137 | 8 | EFO_0000685 | |
| Disease | osteitis deformans | 1.61e-03 | 13 | 137 | 2 | EFO_0004261 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 1.61e-03 | 13 | 137 | 2 | EFO_0800547 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.61e-03 | 13 | 137 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | serum albumin measurement | 1.83e-03 | 592 | 137 | 9 | EFO_0004535 | |
| Disease | Hamman-Rich syndrome | 1.88e-03 | 14 | 137 | 2 | C0085786 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 1.88e-03 | 14 | 137 | 2 | EFO_0020941 | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 1.88e-03 | 14 | 137 | 2 | DOID:874 (biomarker_via_orthology) | |
| Disease | IGFBP-3 measurement | 2.04e-03 | 54 | 137 | 3 | EFO_0004626 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.16e-03 | 15 | 137 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.16e-03 | 15 | 137 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.16e-03 | 15 | 137 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.16e-03 | 15 | 137 | 2 | C0154091 | |
| Disease | anemia (implicated_via_orthology) | 2.16e-03 | 15 | 137 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | body weight | AKAP6 MGAM RELN PDE4B KIZ CEP192 LRP1B KCNRG EYS PHF3 FADS2 ULK4 CLEC10A CALN1 | 2.25e-03 | 1261 | 137 | 14 | EFO_0004338 |
| Disease | vascular endothelial growth factor measurement | 2.27e-03 | 56 | 137 | 3 | EFO_0004762 | |
| Disease | creatinine measurement | CENPF USP11 TRPC1 LAMA2 BIRC6 BRWD3 GAB2 KAT2B PTPN12 PKHD1 FADS2 FH | 2.38e-03 | 995 | 137 | 12 | EFO_0004518 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.44e-03 | 291 | 137 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.48e-03 | 121 | 137 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | eosinophil percentage of leukocytes | 2.59e-03 | 746 | 137 | 10 | EFO_0007991 | |
| Disease | creatine kinase measurement | 2.63e-03 | 59 | 137 | 3 | EFO_0004534 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 2.65e-03 | 398 | 137 | 7 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | hematocrit | VLDLR ASH1L ZFPM1 ADGRL4 ZNF462 PNPLA1 PLCL2 PKHD1 FADS2 ULK4 TASOR TP53BP1 | 2.71e-03 | 1011 | 137 | 12 | EFO_0004348 |
| Disease | Benign neoplasm of stomach | 2.78e-03 | 17 | 137 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.78e-03 | 17 | 137 | 2 | C0496905 | |
| Disease | Antibody Deficiency Syndrome | 2.78e-03 | 17 | 137 | 2 | C0003257 | |
| Disease | Lipidemias | 2.78e-03 | 17 | 137 | 2 | C1706412 | |
| Disease | Carcinoma in situ of stomach | 2.78e-03 | 17 | 137 | 2 | C0154060 | |
| Disease | pre-eclampsia (biomarker_via_orthology) | 2.78e-03 | 17 | 137 | 2 | DOID:10591 (biomarker_via_orthology) | |
| Disease | Hyperlipidemia | 2.78e-03 | 17 | 137 | 2 | C0020473 | |
| Disease | puberty onset measurement | 2.79e-03 | 125 | 137 | 4 | EFO_0005677 | |
| Disease | retinal vasculature measurement | 2.94e-03 | 517 | 137 | 8 | EFO_0010554 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.96e-03 | 127 | 137 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | lysophosphatidylcholine measurement | 3.03e-03 | 62 | 137 | 3 | EFO_0010224 | |
| Disease | Malignant Neoplasms | 3.04e-03 | 128 | 137 | 4 | C0006826 | |
| Disease | mood instability measurement | 3.04e-03 | 128 | 137 | 4 | EFO_0008475 | |
| Disease | lupus nephritis (is_implicated_in) | 3.12e-03 | 18 | 137 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | Carcinoma of bladder | 3.12e-03 | 18 | 137 | 2 | C0699885 | |
| Disease | respiratory syncytial virus infectious disease (is_marker_for) | 3.12e-03 | 18 | 137 | 2 | DOID:1273 (is_marker_for) | |
| Disease | disease free survival | 3.12e-03 | 18 | 137 | 2 | EFO_0000409 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 3.17e-03 | 63 | 137 | 3 | DOID:3083 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SCSVVDVFSQLNQSF | 1186 | Q9UPW8 | |
| TQSCGENANCTNTEG | 66 | Q9HBW9 | |
| QTVDSSNIDGFVNCT | 341 | P21860 | |
| NEGTCIQQDSFSSSE | 496 | Q9NR48 | |
| ENGTVNDQTFHCLQS | 291 | Q8WYN0 | |
| NVQTICNGTVSVASS | 511 | P32519 | |
| CERESANGFETNVAS | 1041 | P29374 | |
| GSTDNESCTNSELNS | 606 | Q9NR09 | |
| SSTTCVRQAQCGQDF | 86 | P07357 | |
| VFAGSSCNDIVCTEQ | 446 | Q676U5 | |
| ITNFGVCSCSENVQE | 1841 | Q86UK0 | |
| NITNASSCFGNEDTN | 791 | Q8NEN0 | |
| TNFSLATAEQCGQET | 41 | Q13304 | |
| CEFVGSENNSVTVEG | 246 | Q9UK96 | |
| GQHQCDSSTVCFNTV | 216 | P48960 | |
| ACQQNTVTSSGDLVA | 666 | Q12802 | |
| GTNAFVGIVNETCDS | 931 | Q5VU97 | |
| CQNSGVQEDSDSSSE | 811 | Q6RI45 | |
| VQFQCSSDSTNGTGV | 496 | Q9Y2F9 | |
| VNGQFESVCESVFSE | 456 | O14490 | |
| NGQFESVCESVFSEV | 536 | Q9P1A6 | |
| NACSQASDFSVQSVA | 796 | Q5JWR5 | |
| SVSSGNQDDCIVNGE | 211 | Q6XZF7 | |
| LNETSGNCQTEFEGV | 206 | Q9BXU9 | |
| IVVTADSSQCANNCG | 1591 | P59510 | |
| CQANQASATSEECTV | 56 | P62877 | |
| VSTNAIFDNSTDSCV | 76 | Q09MP3 | |
| QGFTEIVFCAVTSNE | 571 | Q92830 | |
| GNVNGCSTAEESVSQ | 426 | Q8IZ07 | |
| FSSQLTATCNVEQSF | 356 | O95864 | |
| QAATQESTFQELCEG | 286 | Q9NZM5 | |
| VQASSQCFQSATDVA | 1686 | P46531 | |
| RCSEAGINQTSVQFS | 3211 | Q86XX4 | |
| ADNQLLDENGTTCTF | 821 | Q9NZR2 | |
| TIDASNISCFQNNVE | 501 | Q5TKA1 | |
| QQFCQESLSSEFCSG | 171 | Q5T1H1 | |
| CTSSNEEGTQFCNIT | 211 | Q99795 | |
| QGFTEIVFCAVTSNE | 566 | Q92831 | |
| TVSDCQVGNTTDFCS | 96 | Q04900 | |
| QVGNTTDFCSVSTAT | 101 | Q04900 | |
| SAQDAGAYVCTATNT | 1036 | Q8NDA2 | |
| AQAGTYTCVAENTQA | 3196 | Q8NDA2 | |
| FSTTNVNNATTTCFE | 176 | Q99677 | |
| NEVSNFVDGSVSGCS | 531 | O43451 | |
| ANDDLTTTGTDNCTF | 316 | Q14117 | |
| TTTGTDNCTFNTCQK | 321 | Q14117 | |
| NIDVQTEFSGCLSQD | 116 | Q5H9U9 | |
| EVANSFAVTNAFCSQ | 66 | P42262 | |
| EGDNATFTCSFSNTS | 46 | Q15116 | |
| SSSSQQNNTVLVEGC | 4781 | Q02817 | |
| AITTVSQECFDVENG | 86 | Q07343 | |
| NFENSQDFVPCSQST | 761 | Q8IXT1 | |
| GATCFECEITFSNVN | 576 | Q8IX07 | |
| QSFETGHCLNETNVT | 76 | P23743 | |
| DAITISTFSGQQDIC | 186 | Q8N8W4 | |
| ATVYNATSEETSNNC | 1221 | Q8IZD2 | |
| QSCTETGSENENVSL | 1561 | P50851 | |
| GSVCISDQFNSVNFS | 951 | P48357 | |
| FVQNGTVSTNEFLCD | 176 | P13473 | |
| NCSTVGSLDFQCNVN | 1061 | P24043 | |
| LVFQCGSDSTTDNQT | 176 | Q8N5I3 | |
| QTAQSSNVTDSCVVQ | 196 | Q2M2Z5 | |
| SGSQDFPQCNTIENT | 591 | P28290 | |
| QQTTGSNGSDCTLAQ | 111 | Q96PC2 | |
| SAFSQTECVEVQGEA | 216 | Q6UXL0 | |
| TSFTCQNEQAHTLET | 2171 | Q9UPN3 | |
| IQFEINVGCSTDSSS | 2021 | P78509 | |
| AQQGTESFQCDNGVS | 31 | Q5VYJ5 | |
| NVEKQSSSGTNCSSD | 281 | Q9Y2F5 | |
| SIEQSSNCEAETTFQ | 1381 | Q9Y2F5 | |
| SNCEAETTFQCQIAT | 1386 | Q9Y2F5 | |
| CPQEDVSSSGQSTNF | 1491 | Q9Y2F5 | |
| RCSTSETSGFENQVN | 1856 | Q8N1I0 | |
| CNNSFAECSSQDVVT | 171 | P09603 | |
| VSANQCSVDEVFCSS | 1516 | P49454 | |
| SNCSQGQQLATFSSD | 161 | Q9BQI4 | |
| DAEFSQAVNPQSFCT | 1686 | Q8TD84 | |
| ASVSFTENCVVGIQA | 426 | P07954 | |
| TEGSRFQDCVNEAAS | 206 | Q8ND71 | |
| ISTESLDCEVNNNGS | 991 | Q13873 | |
| TGIFFQAEACVTNDT | 56 | Q9Y2G2 | |
| GNNDQSITECSIATT | 3386 | Q12955 | |
| QNETSSGNLESCAQA | 4201 | Q12955 | |
| QVSSGTSSTQCCQED | 76 | Q14210 | |
| SNVSNATCQFLSGEN | 171 | Q6UX82 | |
| FSGQVSHQTTSENQC | 1211 | Q8TEP8 | |
| SDNQTLCGDQVTFSS | 176 | A0A0U1RQI7 | |
| NAAFNVTVVATNTCG | 56 | P11047 | |
| TSEFTQECQTAFGSP | 361 | Q8NDH6 | |
| EQATQGSECITSASF | 91 | Q96KN3 | |
| ETSVVNCSNNSFSGN | 941 | P56715 | |
| QASVVFCDSTFQDNP | 151 | Q9UGB7 | |
| SICQICGFNQAEEST | 111 | Q9UQC2 | |
| CGFNQAEESTDSLRN | 116 | Q9UQC2 | |
| ITNCSGVTVVFENND | 281 | Q8N9W8 | |
| FGEVTSASNCTDFQS | 416 | Q9NP81 | |
| SEQGTSFSQTCLTQF | 126 | Q9H9J2 | |
| QATNTENEATSGGCV | 76 | Q8NBS3 | |
| HAEENSCVTSNVSTN | 1976 | Q8WUY3 | |
| SCVTSNVSTNEGQET | 1981 | Q8WUY3 | |
| NFGDICSVVGQQATE | 236 | Q8TF05 | |
| NGISDQISEDCAFSV | 206 | Q9UPR0 | |
| SQATECDETQETGSF | 216 | Q9UK23 | |
| NVGDTSQNSCVDCSV | 486 | Q05209 | |
| CDVETQSFQGNVSLS | 1336 | P08F94 | |
| FQNCSCIQTSGNSSA | 481 | P46721 | |
| NEPSSFVNGTTTNQC | 1396 | P14410 | |
| SNGQSITFDAIQEAC | 141 | Q8IWL1 | |
| VCQSSSTVGQSFSEQ | 426 | Q96SB4 | |
| HFESQSVTCDVQNST | 2811 | Q9P2P6 | |
| GNDNICQDDLSITFS | 771 | P11215 | |
| TNSCDNISQFSVDSI | 476 | Q9UBF8 | |
| DSGSCSALQNEFVSE | 131 | Q86XK3 | |
| NAAEACSTTEEVFNS | 956 | Q9NRY4 | |
| ACSSQSQESGEFSLQ | 671 | Q9UQ84 | |
| SNGQSITFDAIQEAC | 141 | Q8IWL2 | |
| FCSQQTETSGQIQGV | 776 | Q8N5C6 | |
| VCLFTDFDSQTNVSQ | 21 | P01848 | |
| IVCSEGENSNSTEQD | 1576 | Q9UK61 | |
| GTEENASISNISCCN | 2026 | Q13023 | |
| SSAEDEIGCNQTTQE | 1281 | P25054 | |
| EIGCNQTTQEADSAN | 1286 | P25054 | |
| QVDNCNVSISTSSDD | 576 | Q6ZVT6 | |
| QVATLNNNASTEGTC | 166 | Q8IUN9 | |
| CEQQSNDTFHSFIGT | 576 | P48995 | |
| FCAESANSQIDTETA | 871 | Q13129 | |
| ATECNCSLGNFDSQV | 386 | Q6P1M0 | |
| VCLFTDFDSQTNVSQ | 156 | P0DTU3 | |
| GASAQASAEQQEAVC | 331 | Q6ZMY3 | |
| QDNSETAEQCGTSSE | 81 | Q6NX45 | |
| FTGQANVVSLCNSAD | 421 | O15344 | |
| DGTQCGETSSQIQDS | 76 | Q96GE5 | |
| GSDNASTDCERTVFQ | 261 | O43847 | |
| DGNVSCSENLVANTA | 1626 | Q92576 | |
| NVCEQGTSTVDQNFG | 1176 | Q12888 | |
| SNNGTGAEQACEVSV | 2056 | Q86WI1 | |
| FLACCSQDAQGQETT | 441 | Q13472 | |
| GESNSVTCNCGQEAV | 806 | Q13472 | |
| QNGSIGCVENVDASS | 231 | Q9Y6W5 | |
| LQFAADAEVSTVSNC | 206 | Q6ZNB5 | |
| DGTQCGETSSQIQDS | 76 | Q9Y2A4 | |
| DSTNTGVNCVDAGNI | 351 | Q9P272 | |
| CGSVNASNQTEVEFS | 46 | Q96JM2 | |
| VQEGEDFTTYCNSST | 31 | A0A0B4J276 | |
| DQDSSTFPGCINNAT | 121 | P51784 | |
| IVESCSQLQGFQSEE | 81 | Q9H808 | |
| NVCTTFSAQSQGFIT | 631 | Q96C45 | |
| GENDSLSQCFTGTQS | 381 | Q9Y6Q6 | |
| NVEENGRDCQSTATT | 741 | P98155 | |
| ASSGQCFTVENADAV | 176 | B1AL88 | |
| EAFGNACTIINDNSS | 471 | Q8NEV4 |